Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001213900-22-010599

Options or other derivatives

  • Chief Commercial Officer acquired 17,508 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Silvestro Stephen L · Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-03-01 Grant or award : show line 1 in the form Stock Option +11,726 $43.24 2027-03-01 11,726 11,726 D
2022-03-01 Grant or award : show line 2 in the form Restricted Stock Units +5,782 5,782 5,782 D
Loading xslF345X03/ownership.xml…